Kevin X. Chen

1.3k total citations
23 papers, 562 citations indexed

About

Kevin X. Chen is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Kevin X. Chen has authored 23 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hepatology, 18 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Kevin X. Chen's work include Hepatitis C virus research (19 papers), HIV/AIDS drug development and treatment (18 papers) and Hepatitis B Virus Studies (8 papers). Kevin X. Chen is often cited by papers focused on Hepatitis C virus research (19 papers), HIV/AIDS drug development and treatment (18 papers) and Hepatitis B Virus Studies (8 papers). Kevin X. Chen collaborates with scholars based in United States, Switzerland and United Kingdom. Kevin X. Chen's co-authors include F. George Njoroge, Neng‐Yang Shih, John J. Piwinski, Viyyoor Girijavallabhan, Andrew Prongay, John Pichardo, Vincent Madison, Ashok Arasappan, Kuo-Chi Cheng and Bancha Vibulbhan and has published in prestigious journals such as Angewandte Chemie International Edition, Accounts of Chemical Research and Journal of Medicinal Chemistry.

In The Last Decade

Kevin X. Chen

23 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin X. Chen United States 14 233 211 210 163 112 23 562
John Pichardo United States 15 153 0.7× 163 0.8× 205 1.0× 146 0.9× 120 1.1× 30 458
Élise Ghiro Canada 11 258 1.1× 210 1.0× 251 1.2× 166 1.0× 120 1.1× 15 582
Yves Bousquet Canada 13 258 1.1× 195 0.9× 220 1.0× 211 1.3× 113 1.0× 15 575
Ashok Arasappan United States 17 346 1.5× 203 1.0× 147 0.7× 122 0.7× 83 0.7× 31 559
Stefania Colarusso Italy 12 218 0.9× 184 0.9× 295 1.4× 174 1.1× 144 1.3× 16 619
Vida Gorys Canada 14 419 1.8× 296 1.4× 347 1.7× 230 1.4× 139 1.2× 21 827
Chantal Grand‐Maître Canada 15 360 1.5× 308 1.5× 95 0.5× 151 0.9× 104 0.9× 23 663
Gulrez Fazal Canada 13 256 1.1× 207 1.0× 371 1.8× 267 1.6× 275 2.5× 16 810
Hiromasa Hashimoto Japan 14 409 1.8× 298 1.4× 143 0.7× 113 0.7× 78 0.7× 25 828
Shintaro Hirashima Japan 8 255 1.1× 76 0.4× 142 0.7× 99 0.6× 71 0.6× 8 428

Countries citing papers authored by Kevin X. Chen

Since Specialization
Citations

This map shows the geographic impact of Kevin X. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin X. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin X. Chen more than expected).

Fields of papers citing papers by Kevin X. Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin X. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin X. Chen. The network helps show where Kevin X. Chen may publish in the future.

Co-authorship network of co-authors of Kevin X. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin X. Chen. A scholar is included among the top collaborators of Kevin X. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin X. Chen. Kevin X. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhola, Neil E., Yuping Chen, Kevin X. Chen, et al.. (2023). Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor. Cancer Research Communications. 3(9). 1731–1742. 2 indexed citations
2.
3.
Chen, Kevin X. & F. George Njoroge. (2010). The Journey to the Discovery of Boceprevir: An NS3–NS4 HCV Protease Inhibitor for the Treatment of Chronic Hepatitis C. Progress in medicinal chemistry. 49. 1–36. 21 indexed citations
4.
Bennett, Frank, Yuhua Huang, Siska Hendrata, et al.. (2010). The introduction of P4 substituted 1-methylcyclohexyl groups into Boceprevir®: A change in direction in the search for a second generation HCV NS3 protease inhibitor. Bioorganic & Medicinal Chemistry Letters. 20(8). 2617–2621. 23 indexed citations
5.
Chen, Kevin X., et al.. (2009). A review of HCV protease inhibitors.. PubMed. 10(8). 821–37. 31 indexed citations
6.
Chen, Kevin X., Bancha Vibulbhan, Weiying Yang, et al.. (2009). Novel potent inhibitors of hepatitis C virus (HCV) NS3 protease with cyclic sulfonyl P3 cappings. Bioorganic & Medicinal Chemistry Letters. 19(4). 1105–1109. 11 indexed citations
7.
Nair, Latha G., Mousumi Sannigrahi, Stéphane Bogen, et al.. (2009). P4 capped amides and lactams as HCV NS3 protease inhibitors with improved potency and DMPK profile. Bioorganic & Medicinal Chemistry Letters. 20(2). 567–570. 11 indexed citations
8.
Arasappan, Ashok, Edwin Jao, Frank Bennett, et al.. (2009). Toward Second Generation Hepatitis C Virus NS3 Serine Protease Inhibitors: Discovery of Novel P4 Modified Analogues with Improved Potency and Pharmacokinetic Profile. Journal of Medicinal Chemistry. 52(9). 2806–2817. 11 indexed citations
9.
Njoroge, F. George, Kevin X. Chen, Neng‐Yang Shih, & John J. Piwinski. (2008). Challenges in Modern Drug Discovery: A Case Study of Boceprevir, an HCV Protease Inhibitor for the Treatment of Hepatitis C Virus Infection. Accounts of Chemical Research. 41(1). 50–59. 195 indexed citations
10.
Chen, Kevin X., Bancha Vibulbhan, Weiying Yang, et al.. (2007). Potent and selective small molecule NS3 serine protease inhibitors of Hepatitis C virus with dichlorocyclopropylproline as P2 residue. Bioorganic & Medicinal Chemistry. 16(4). 1874–1883. 5 indexed citations
11.
Arasappan, Ashok, F. George Njoroge, Kevin X. Chen, et al.. (2006). P2–P4 Macrocyclic inhibitors of hepatitis C virus NS3-4A serine protease. Bioorganic & Medicinal Chemistry Letters. 16(15). 3960–3965. 16 indexed citations
12.
Chen, Kevin X., F. George Njoroge, Ashok Arasappan, et al.. (2006). Novel Potent Hepatitis C Virus NS3 Serine Protease Inhibitors Derived from Proline-Based Macrocycles. Journal of Medicinal Chemistry. 49(3). 995–1005. 25 indexed citations
13.
Chen, Kevin X., F. George Njoroge, Bancha Vibulbhan, et al.. (2005). Proline‐Based Macrocyclic Inhibitors of the Hepatitis C Virus: Stereoselective Synthesis and Biological Activity. Angewandte Chemie International Edition. 44(43). 7024–7028. 10 indexed citations
14.
Chen, Kevin X., F. George Njoroge, Andrew Prongay, et al.. (2005). Synthesis and biological activity of macrocyclic inhibitors of hepatitis C virus (HCV) NS3 protease. Bioorganic & Medicinal Chemistry Letters. 15(20). 4475–4478. 15 indexed citations
15.
Chen, Kevin X., F. George Njoroge, Andrew Prongay, et al.. (2005). Synthesis and Biological Activity of Macrocyclic Inhibitors of Hepatitis C Virus (HCV) NS3 Protease.. ChemInform. 37(2). 1 indexed citations
16.
Chen, Kevin X., F. George Njoroge, Bancha Vibulbhan, et al.. (2005). Proline‐Based Macrocyclic Inhibitors of the Hepatitis C Virus: Stereoselective Synthesis and Biological Activity. Angewandte Chemie. 117(43). 7186–7190. 1 indexed citations
17.
Chen, Kevin X., F. George Njoroge, John Pichardo, et al.. (2005). Potent 7-Hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid-Based Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease. Journal of Medicinal Chemistry. 49(2). 567–574. 29 indexed citations
18.
Chen, Kevin X., F. George Njoroge, John Pichardo, et al.. (2005). Design, Synthesis, and Biological Activity of m-Tyrosine-Based 16- and 17-Membered Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease. Journal of Medicinal Chemistry. 48(20). 6229–6235. 19 indexed citations
19.
Chen, Kevin X., F. George Njoroge, Bancha Vibulbhan, et al.. (2002). Syntheses of Novel 4-tert-Alkyl Ether Proline-Based 16- and 17-Membered Macrocyclic Compounds. The Journal of Organic Chemistry. 67(8). 2730–2733. 9 indexed citations
20.
Arasappan, Ashok, et al.. (2002). Novel Dipeptide Macrocycles from 4-Oxo, -Thio, and -Amino-Substituted Proline Derivatives. The Journal of Organic Chemistry. 67(11). 3923–3926. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Pichardo Breakdown of academic impact, for papers by Élise Ghiro Breakdown of academic impact, for papers by Yves Bousquet Breakdown of academic impact, for papers by Ashok Arasappan Breakdown of academic impact, for papers by Stefania Colarusso Breakdown of academic impact, for papers by Vida Gorys Breakdown of academic impact, for papers by Chantal Grand‐Maître Breakdown of academic impact, for papers by Gulrez Fazal Breakdown of academic impact, for papers by Hiromasa Hashimoto Breakdown of academic impact, for papers by Shintaro Hirashima
Rankless by CCL
2026